| European Leukemia Trial Registry |
| Trial: ALL GRAAPH 02/2005 |
| Title | Imatinib-based vs. standard imatinib containing Hyper CVAD induction in de novo Ph+ ALL |
| Scientific Title | A Randomized Multicenter Phase III Study to Assess the Non-inferiority in Efficacy and Compare the Toxicity of an Imatinib-based to a Standard Imatinib-containing HyperCVAD Induction in Younger Adults with de novo Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph1- ALL). |
| Short Title | ALL GRAAPH 02/2005 |
| Trialgroup | GRAALL |
| Type of Trial | randomized, multicentric |
| Disease | Acute lymphoblastic leukemia(ALL) PH+ALL/BCR-ABL |
| Age | 15-59 years |
| Status | Active |
| Start of Recruitment | 25.11.2005 |
| Leader | Dombret, Prof. Dr. med., Hervé |
| Contactperson |
principal investigator
principal investigator |
| Centre of Trial | Assistance Publique-Hôpitaux de Paris, France |
| Shortprotocol | Shortprotocol |
